ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions

Leigh Turner

doi:10.1016/j.stemcr.2021.05.011

ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions

Leigh Turner

Center for Bioethics

Research output: Contribution to journal › Short survey › peer-review

6 Scopus citations

Abstract

The ISSCR's revised Guidelines for Stem Cell Research and Clinical Translation reflect the organization's commitment to opposing premature commercialization of stem cell-based interventions and supporting the development of products that meet stringent ethical, scientific, and regulatory standards. The Guidelines contain five important new recommendations concerning clinical translation of stem cell products.

Original language	English (US)
Pages (from-to)	1394-1397
Number of pages	4
Journal	Stem Cell Reports
Volume	16
Issue number	6
DOIs	https://doi.org/10.1016/j.stemcr.2021.05.011
State	Published - Jun 8 2021

Bibliographical note

Publisher Copyright:
© 2021 The Author

Access

10.1016/j.stemcr.2021.05.011

OpenUrl availability

Full text

Cite this

@article{c51495fd9a3d404085800420d1c91564,

title = "ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions",

abstract = "The ISSCR's revised Guidelines for Stem Cell Research and Clinical Translation reflect the organization's commitment to opposing premature commercialization of stem cell-based interventions and supporting the development of products that meet stringent ethical, scientific, and regulatory standards. The Guidelines contain five important new recommendations concerning clinical translation of stem cell products.",

author = "Leigh Turner",

note = "Publisher Copyright: {\textcopyright} 2021 The Author",

year = "2021",

month = jun,

day = "8",

doi = "10.1016/j.stemcr.2021.05.011",

language = "English (US)",

volume = "16",

pages = "1394--1397",

journal = "Stem Cell Reports",

issn = "2213-6711",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - ISSCR's Guidelines for Stem Cell Research and Clinical Translation

T2 - Supporting development of safe and efficacious stem cell-based interventions

AU - Turner, Leigh

PY - 2021/6/8

Y1 - 2021/6/8

N2 - The ISSCR's revised Guidelines for Stem Cell Research and Clinical Translation reflect the organization's commitment to opposing premature commercialization of stem cell-based interventions and supporting the development of products that meet stringent ethical, scientific, and regulatory standards. The Guidelines contain five important new recommendations concerning clinical translation of stem cell products.

AB - The ISSCR's revised Guidelines for Stem Cell Research and Clinical Translation reflect the organization's commitment to opposing premature commercialization of stem cell-based interventions and supporting the development of products that meet stringent ethical, scientific, and regulatory standards. The Guidelines contain five important new recommendations concerning clinical translation of stem cell products.

UR - http://www.scopus.com/inward/record.url?scp=85107116125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107116125&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2021.05.011

DO - 10.1016/j.stemcr.2021.05.011

M3 - Short survey

C2 - 34048693

AN - SCOPUS:85107116125

SN - 2213-6711

VL - 16

SP - 1394

EP - 1397

JO - Stem Cell Reports

JF - Stem Cell Reports

IS - 6

ER -

ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions

Abstract

Bibliographical note

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this